🟢 Neurosense Therapeutics is trading 8% up in pre-market as S&P 500 and NASDAQ Composite rise

Neurosense Therapeutics is trading at $6.86, up 8.03% in pre-market with the move best attributed to broad risk-on sentiment.

• S&P 500 is up 0.65% and NASDAQ Composite is up 1.10%.
• No fresh company-specific announcement dated September 21, 2026, was identified.
• Recent coverage centers on the 1-for-20 reverse split and September 14–16 investor conference participation, suggesting post-split volatility rather than a new catalyst; broad risk-on sentiment remains the best attribution, with limited company-specific evidence.